Caranx Medical Gets FDA OK for AI Software Guiding Heart Valve Implants
Caranx Medical (“Caranx”), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving procedure, today announced FDA clearance for US commercialization of the world’s first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation. The FDA clearance marks a…
